Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies
Arab Journal of Gastroenterology · 2023-11 · 24 (4) · 198-203
DOI: 10.1016/j.ajg.2023.09.005 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Arab Journal of Gastroenterology, 2023-11. Verfasst von Inácio Lima Silva Aguiar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Program in Medicine and Health, School of Medicine, Federal University of Bahia, Salvador, Bahia, Brazil. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Periodontal Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado da Bahia, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease, comprising hepatic steatosis, and non-alcoholic steatohepatitis. Periodontal disease (PD) may be a risk factor for the evolution of liver cirrhosis. This study aimed to evaluate the association between NAFLD and PD.We searched in Pubmed, Scopus, Cochrane, and Lilacs databases with descriptors (Non-alcoholic Fatty Liver Disease OR (non-alcoholic AND Fatty Liver AND disease) OR Nonalcoholic Steatohepatitis) AND (Periodontal Disease OR Gingivitis OR Periodontitis) from January 2021 to September 2021. We selected, by the abstract, cross-sectional, cohort (prospective and retrospective), and case-control studies that address periodontal disease in patients with Non-alcoholic Fatty Liver Disease, and aged ≥ 18 years. The search was without the restriction of language and publication time.The search resulted in 954 articles. After applying the selection criteria, five cross-sectional studies remained. A metanalysis combined the study estimates of periodontal disease in NAFLD, by using the random effects. The Odds Ratio (1.91; 95% CI 1.21-3.02; P = 0.006) indicates that the chance of presenting Periodontal disease is 91% higher in individuals with NAFLD when compared with individuals without NAFLD. There are few studies with appropriate methodology to produce sound evidence about the causal relationship between the use of NAFLD and PD, however, studies support the association. So, dental staff must be aware of this association for better management of periodontal disease in patients with NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Program in Medicine and Health, School of Medicine, Federal University of Bahia, Salvador, Bahia, Brazil.
- Program in Medicine and Health, School of Medicine, Federal University of Bahia, Salvador, Bahia, Brazil. Electronic address: liliane.lins@ufba.br.
Förderung
- Fundação de Amparo à Pesquisa do Estado da Bahia
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Aguiar, I. L. S., Santos-Lins, L. S., Brasil-Oliveira, R., Cotrim, H. P., & Lins-Kusterer, L. (2023). Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies. Arab Journal of Gastroenterology, 24(4), 198-203. https://doi.org/10.1016/j.ajg.2023.09.005
Vancouver
Aguiar ILS, Santos-Lins LS, Brasil-Oliveira R, Cotrim HP, Lins-Kusterer L. Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies. Arab Journal of Gastroenterology. 2023;24(4):198-203. doi:10.1016/j.ajg.2023.09.005
BibTeX
@article{Aguiar2023,
author = {Aguiar, Inácio Lima Silva and Santos-Lins, Larissa Souza and Brasil-Oliveira, Rebeca and Cotrim, Helma Pinchemel and Lins-Kusterer, Liliane},
title = {Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies},
journal = {Arab Journal of Gastroenterology},
year = {2023},
volume = {24},
number = {4},
pages = {198--203},
doi = {10.1016/j.ajg.2023.09.005}
}
EUVIMED